HSIC vs TECX · P/E 24, rev $12.67B vs $567.2M cap
Henry Schein Inc (HSIC) versus Tectonic Therapeutic, Inc. (TECX) — a side-by-side from cached financials, not a winner call.
Henry Schein Inc (HSIC) is a medical distribution company listed on NASDAQ.
Tectonic Therapeutic, Inc. (TECX) is a biotechnology company listed on NASDAQ.
Latest reported HSIC revenue for 2024-12-28 was $12.67B. Net income was $398.0M. Revenue was up 2.7% from 2023-12-30 to 2024-12-28. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
TECX does not have a complete income-statement cache yet.
HSIC currently screens at market cap $9.11B and trailing P/E 24.2. TECX currently screens at market cap $567.2M.
Not investment advice. Open the HSIC and TECX stock pages for the full models.
Not investment advice.